MEDICAL DEVICES · SERVICE DETAILS

Annual renewal and annual update of listing of companies

Reconciling current operations, official fees, contacts and listing data at the annual window around established facilities and product records, collaborating to renew and apply updates, preserving actual submissions and completing records.

Payments are not equal to completion of the renewal period. Annual registration and listing review are to be implemented separately and product licensing, UDI/GUDID and routine changes are to be verified separately; Registration records do not represent FDA approval or inspection.

SERVICE OVERVIEW

What does this service help with?

Identify differences in costs and information by comparing the previous year’s records with the current facilities, activities, U.S. priorities and product status. The agreed delivery of the annual checklist, renewal updates and completion of records would clarify residual issues and next responsibilities.

WHO MAY NEED IT

Who should consider this service?

Applied enterprises that have a record of registration or listing of U.S. instruments, require annual renewal and review of listings over the same period; First-time processing, withdrawal from the operation or complex subject changes should be judged separately.

SCOPE & APPROACH

What could the annual business renewal and annual update of listing include?

Annual reviews, actual submissions and routine changes are confirmed separately and are not performed in lieu of the original records, where no change has been made or payments have been made.

01

Annual status and range reconciliation

Identify existing facilities, responsible subjects, record-keeping and ongoing operations, and distinguish between renewal, activation, first or withdrawal.

02

Review of account privileges and contact information

Check the applicable information and authorizations of Owner/Operator, Office Correspondent, agents, etc., to resolve problems of inaccessibility or inconsistencies of information in advance.

03

Recognition of official annual fees and payments

Check the confirmation of payments against fiscal year reconciliation rates and payables; If an exemption is to be assessed, additional qualifications, historical records and independent application requirements are to be approved.

04

Annual renewal and change reconciliation of facilities

Review facilities and activities at the applicable annual window and collaborative submission; No changes are also processed for annual submissions, and when changes are made, they are updated as they are true.

05

product listing Annual Review and Update

(b) Deal with an agreed listing update against existing products, manufacturing relationships and commercial distribution status; Pre-market conditions and UDI changes are assessed separately.

06

Verification is completed and annual records are handed over

Maintenance of payments, submission and completion of records, inspection of affected information, handover of annual inventories, legacy and ongoing maintenance responsibilities.

GET READY

What to prepare for the assessment

Initial communication may be preceded by a summary and a catalogue of existing records; Detailed information is transferred to the confidentiality arrangements under delegated authority.

  • Existing facility registrations, listings and records completed in previous year
  • Current facility address, activities, responsible persons and agents
  • Account permissions, delegated authority and information contacts
  • List of products and manufacturing relationships, suspension restoration and other changes
  • Record of application of official payments or exemptions granted during the fiscal year
  • Scope of the proposed renewal, historical issues and expected handover arrangements
HOW TO START

From initial review to engagement

STEP 01

Comparison of existing and current operations

Check facilities, products, account numbers and annual scope to include information to be completed.

STEP 02

List of identified costs and changes

Review of actual data, fees payable and competence, and agreement on the scope of this processing.

STEP 03

Annual submissions and updates of collaborations

Process extension and listing updates in the window to reconcile feedback and completion status.

STEP 04

Responsibility for delivering records and maintaining them

Hand-over of evidence, discrepancies and legacy, suggesting subsequent changes to be dealt with separately.

Payments are not equal to completion of the renewal period. Annual registration and listing review are to be implemented separately and product licensing, UDI/GUDID and routine changes are to be verified separately; Registration records do not represent FDA approval or inspection.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FY 2027, October 1, 2026 through September 30, 2027. For other charges, use the FDA rules as of the review date.

Timing and preparation

Document preparation

Reconciling facility, account number privileges, agent, listing and payment information on a case-by-case basis prior to renewal. Historical data discrepancies, main changes or lack of access to accounts affect scheduling and should be processed in advance.

FDA processing

Annual registration is submitted from 1 October to 31 December of each year, even if no change has occurred; Review and update listings with the same window. The annual window is not the number of days of service delivery and the time allowed for payment and data verification.

Fee breakdown

FDA fees

FY 2027 US$13,785 for annual establishment registration fees. The exemption for the annual fee of a particular small business is subject to verification and determination by the FDA of the condition that the related party’s revenue does not exceed US$ 1 million, financial difficulties and registration of previous payments; It is not a general small business discount and does not apply to first registration. The timing of the application and the specific evidence are additional to the current requirements of the FDA.

Service fees

Bids indicating whether complex changes, agents and ongoing services are otherwise accounted for by facility-to-product range, annual information reconciliation, renewal updates, account number and historical issues processing and handover.

Other possible costs

U.S. agent, translator and other special jobs are listed separately. New pre-market declarations, UDI or technical changes in products are not automatically included in the annual renewal service.

OFFICIAL SOURCES

Official grounds for application and maintenance

Data check: 2026-11-06. Specific obligations shall be confirmed in conjunction with the equipment, activities and current application requirements of the FDA.

START WITH YOUR PRODUCT

Please provide a record of the change from the previous year to the current year.

The confirmation of facilities, agents, products and accounts will be preceded by a judgement on renewal, renewal or other applicable matters. Please check whether the commodities contain this renewal and the scope of the listing prior to the self-help list, subject to confirmation of the order.